PSA-detected (clinical stage T1c or B0) prostate cancer: Pathologically significant tumors

J. E. Oesterling, V. J. Suman, H. Zincke, D. G. Bostwick

Research output: Contribution to journalArticlepeer-review

95 Scopus citations

Fingerprint

Dive into the research topics of 'PSA-detected (clinical stage T1c or B0) prostate cancer: Pathologically significant tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences